Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor d-1-methyl-tryptophan-Reference-Cited by-同舟云学术

Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor d-1-methyl-tryptophan

Published:2017-02-23 Issue:1 Volume:10 Page:
ISSN:1756-8722
Container-title:Journal of Hematology & Oncology
language:en
Short-container-title:J Hematol Oncol

Author:

Zhang Xiaolong,Yang Yuanyuan,Zhang Leisheng,Lu Yang,Zhang Qing,Fan Dongmei,Zhang Yizhi,Zhang Yanjun,Ye Zhou,Xiong Dongsheng

Funder

National Natural Science Foundation of China

National Science and Technology Major Project of China

CAMS Initiative for Innovative Medicine

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Biology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/s13045-017-0397-z.pdf

Reference47 articles.

1. Grillo-Lopez AJ, White CA, Dallaire BK, Varns CL, Shen CD, Wei A, et al. Rituximab: the first monoclonal antibody approved for the treatment of lymphoma. Curr Pharm Biotechnol. 2000;1(1):1–9.

2. Hato T, Yamanouchi J, Tamura T, Hojo N, Niiya Y, Kohno M, et al. Existence of leukemic clones resistant to both imatinib mesylate and rituximab before drug therapies in a patient with Philadelphia chromosome-positive acute lymphocytic leukemia. Int J Hematol. 2004;80:62–6.

3. Baeuerle PA, Kufer P, Lutterbuse R. Bispecific antibodies for polyclonal T-cell engagement. Curr Opin Mol Ther. 2003;5:413–9.

4. Kaplan JB, Grischenko M, Giles FJ. Blinatumomab for the treatment of acute lymphoblastic leukemia. Invest New Drugs. 2015;33:1271–9.

5. Viardot A, Goebeler M-E, Hess G, Neumann S, Pfreundschuh M, Adrian N, et al. Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma. Blood. 2016;127:1410–6.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Historical Overview of Stem Cells;Stem Cells in Clinical Application and Productization;2024-02-21

2. A highly sensitive and specific Homo1‐based real‐time qPCR method for quantification of human umbilical cord mesenchymal stem cells in rats;Biotechnology Journal;2024-02

3. Human Pluripotent Stem Cell-Derived Mesenchymal Stem Cells for Oncotherapy;Advances in Pluripotent Stem Cells;2024-01-31

4. The Role of Mesenchymal Stem Cells in Cancer Immunotherapy;Current Stem Cell Research & Therapy;2023-11

5. MSC-Derived Exosomes for Tissue Engineering and Disease Intervention;Exosomes - Recent Advances From Bench to Bedside;2023-09-13